How to interpret risk reduction numbers in probiotic studies?
Over the last few decades there has been a rapid acceleration in the number of published studies and clinical trials focused on probiotic and prebiotic interventions. One common result that is reported is the change in risk of a condition or outcome after taking a probiotic or prebiotic supplement. News articles and broadcasts commonly highlight claims in clinical trials (e.g., “this trial suggests a 33% reduction in X…"). However, in a world where news is sometimes transmitted in 140 characters or less, much nuance from a proper clinical trial can be lost. When assessing claims of risk reduction, it is important to evaluate and interpret these results in their proper context.
Here are a few tips from the International Association of Pre- and Probiotics
Klik op het menu voor inhoud en andere functies.
Gebruik de pijlen aan de zijkant om door het magazine te bladeren.